Literature DB >> 12414429

Rhegmatogenous retinal detachment after transscleral local resection of choroidal melanoma.

Bertil Damato1, Carl P Groenewald, Jim N McGalliard, David Wong.   

Abstract

OBJECTIVE: To report on the incidence and outcome of rhegmatogenous retinal detachment after transscleral local resection of choroidal melanoma.
DESIGN: Prospective, noncomparative, interventional case series. PARTICIPANTS: One hundred fifty-six patients with choroidal melanoma treated by transscleral local resection between January 1993 and June 2000. INTERVENTION: Transscleral choroidectomy or cyclochoroidectomy for uveal melanoma, with ocular decompression by single-port pars plana vitrectomy and, in most patients, adjunctive ruthenium plaque radiotherapy. MAIN OUTCOME MEASURES: Incidence of rhegmatogenous retinal detachment according to predictive factors and outcomes reported in terms of anatomic success, visual acuity, and ocular conservation.
RESULTS: Rhegmatogenous retinal detachment occurred in 28 (18%) eyes and was significantly more common in patients with thick tumors (Cox univariate analysis, P = 0.001) and in males (Cox univariate analysis, P = 0.013), with posterior tumor extension being of borderline significance (Cox univariate analysis, P = 0.069). Surgical treatment of the retinal detachment was performed in 25 patients; it was undertaken at our center in 22 patients and at the referring hospital in 3 patients. Anatomic success was achieved in 21 (84%) of these 25 patients, with 7 eyes retaining counting fingers vision, and 3 eyes seeing 6/60 or better. Ten eyes treated for retinal detachment were enucleated because of recurrent tumor (four eyes), retinal detachment (three eyes), wound dehiscence (one eye), phthisis (one eye), and poor visual acuity (one eye). Eleven eyes known to have a retinal tear underwent prophylactic vitreoretinal surgery at the end of the local resection, with only one (9%) of these subsequently developing retinal detachment.
CONCLUSIONS: Rhegmatogenous retinal detachment after transscleral choroidectomy or cyclochoroidectomy for uveal melanoma is a serious complication requiring early vitreoretinal surgery.

Entities:  

Mesh:

Year:  2002        PMID: 12414429     DOI: 10.1016/s0161-6420(02)01240-x

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  11 in total

1.  Differences in uveal melanomas between men and women from the British Isles.

Authors:  B E Damato; S E Coupland
Journal:  Eye (Lond)       Date:  2011-11-11       Impact factor: 3.775

2.  Transscleral local resection versus iodine brachytherapy for uveal melanomas that are large because of tumour height.

Authors:  Ilkka Puusaari; Bertil Damato; Tero Kivelä
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-11-18       Impact factor: 3.117

3.  Progress in the management of patients with uveal melanoma. The 2012 Ashton Lecture.

Authors:  B Damato
Journal:  Eye (Lond)       Date:  2012-06-29       Impact factor: 3.775

4.  Incidence and indications for pars plana vitrectomy following the treatment of posterior uveal melanomas in Scotland.

Authors:  S N Chia; H B Smith; H M Hammer; E G Kemp
Journal:  Eye (Lond)       Date:  2015-03-20       Impact factor: 3.775

5.  Core Endoresection as Neoadjuvant Treatment of Uveal Melanoma.

Authors:  Iwona Rospond-Kubiak; Carl Groenewald; Sarah E Coupland; Bertil Damato
Journal:  Ocul Oncol Pathol       Date:  2015-09-24

6.  Eccentric ruthenium plaque radiotherapy of posterior choroidal melanoma.

Authors:  Andrea Russo; Michela Laguardia; Bertil Damato
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-02-23       Impact factor: 3.117

7.  Initial results of fractionated CyberKnife radiosurgery for uveal melanoma.

Authors:  Faruk Zorlu; Ugur Selek; Hayyam Kiratli
Journal:  J Neurooncol       Date:  2009-02-22       Impact factor: 4.130

8.  Neoadjuvant proton beam irradiation vs. adjuvant ruthenium brachytherapy in transscleral resection of uveal melanoma.

Authors:  Alexander Böker; Daniel Pilger; Dino Cordini; Ira Seibel; Aline I Riechardt; Antonia M Joussen; Nikolaos E Bechrakis
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-06-16       Impact factor: 3.117

9.  Transscleral resection without hypotensive anaesthesia vs iodine-125 plaque brachytherapy in the treatment of choroidal melanoma.

Authors:  J M Caminal; N Padrón-Pérez; L Arias; C Masuet-Aumatell; C Gutiérrez; J M Piulats; J Pera; J Català; M J Rubio; J Arruga
Journal:  Eye (Lond)       Date:  2016-04-01       Impact factor: 3.775

Review 10.  Choroidal Melanoma Resection.

Authors:  Hany S Hamza; Abdelrahman M Elhusseiny
Journal:  Middle East Afr J Ophthalmol       Date:  2018 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.